Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Immunological features that determine the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2

Takahiro Kageyama, Shigeru Tanaka, Keishi Etori, Koto Hattori, Kazusa Miyachi, Tadamichi Kasuya, Taro Iwamoto, Kei Ikeda, Hidetoshi Igari, Koutaro Yokote, Hiroshi Nakajima
doi: https://doi.org/10.1101/2021.06.21.449182
Takahiro Kageyama
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Tanaka
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keishi Etori
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koto Hattori
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazusa Miyachi
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadamichi Kasuya
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taro Iwamoto
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kei Ikeda
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidetoshi Igari
2Department of Infectious Diseases, Chiba University Hospital, Graduate School of Medicine Chiba University, Chiba, Japan
3Chiba University Hospital COVID-19 Vaccine Center, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koutaro Yokote
4Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Nakajima
1Department of Allergy and Clinical Immunology, Graduate School of Medicine, Graduate School of Medicine Chiba University, Chiba, Japan
3Chiba University Hospital COVID-19 Vaccine Center, Graduate School of Medicine Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nakajimh@faculty.chiba-u.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

ABSTRACT

We analyzed peripheral blood mononuclear cells (PBMCs) of each 20 individuals with a high anti-SARS-CoV-2 antibody titer and a low antibody titer out of 1,774 healthcare workers who received BNT162b2 mRNA vaccine. A higher antibody titer was associated with the frequencies of naïve and transitional B cells before vaccination. In addition, fold changes in the frequency of activated CD8+ T cells upon vaccination were correlated with the antibody titers.

Competing Interest Statement

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 21, 2021.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Immunological features that determine the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunological features that determine the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
Takahiro Kageyama, Shigeru Tanaka, Keishi Etori, Koto Hattori, Kazusa Miyachi, Tadamichi Kasuya, Taro Iwamoto, Kei Ikeda, Hidetoshi Igari, Koutaro Yokote, Hiroshi Nakajima
bioRxiv 2021.06.21.449182; doi: https://doi.org/10.1101/2021.06.21.449182
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Immunological features that determine the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
Takahiro Kageyama, Shigeru Tanaka, Keishi Etori, Koto Hattori, Kazusa Miyachi, Tadamichi Kasuya, Taro Iwamoto, Kei Ikeda, Hidetoshi Igari, Koutaro Yokote, Hiroshi Nakajima
bioRxiv 2021.06.21.449182; doi: https://doi.org/10.1101/2021.06.21.449182

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Immunology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4237)
  • Biochemistry (9159)
  • Bioengineering (6797)
  • Bioinformatics (24054)
  • Biophysics (12149)
  • Cancer Biology (9564)
  • Cell Biology (13819)
  • Clinical Trials (138)
  • Developmental Biology (7654)
  • Ecology (11731)
  • Epidemiology (2066)
  • Evolutionary Biology (15536)
  • Genetics (10664)
  • Genomics (14352)
  • Immunology (9504)
  • Microbiology (22883)
  • Molecular Biology (9120)
  • Neuroscience (49092)
  • Paleontology (357)
  • Pathology (1487)
  • Pharmacology and Toxicology (2576)
  • Physiology (3851)
  • Plant Biology (8349)
  • Scientific Communication and Education (1473)
  • Synthetic Biology (2300)
  • Systems Biology (6204)
  • Zoology (1302)